神经肌肉疾病的外科手术管理:叙述性综述
Aparna Bhat1, Jason Dean1, Loutfi S Aboussouan1
1Respiratory and Neurological Institutes, Cleveland Clinic, Cleveland, OH 44195, USA.
Journal of clinical medicine
|May 25, 2024
概括
患有神经肌肉疾病的患者面临显著的术后风险,包括呼吸道和心脏问题. 本综述强调了所有手术阶段的关键干预措施,以改善这一弱势群体的结果.
科学领域:
- 麻醉学 麻醉学
- 神经学 神经学
- 关键护理医学 关键护理医学
背景情况:
- 患有神经肌肉疾病 (NMDs) 的患者在术后期表现出更高的脆弱性.
- 他们面临肺部和心脏并发症,药物不良反应和温度调节问题的风险增加.
研究的目的:
- 提高对NMD患者独特的外科手术挑战的认识.
- 为临床医生指导术后评估和干预,以获得有利的外科治疗结果.
主要方法:
- 本综述综合了NMD患者术后管理的当前知识.
- 它强调风险识别,手术前评估,手术内策略和手术后护理.
主要成果:
- 术前评估对于识别风险和启动诸如心脏病咨询或肺功能测试等干预措施至关重要.
- 术内管理需要对患者的位置,呼吸道控制,麻醉和通风进行仔细的注意.
- 手术后的护理包括管理电解质失衡,分泌物,疼痛和药物,以防止复发症,如重新输管.
结论:
- 积极和量身定制的术后管理对于减轻NMD患者的风险至关重要.
- 在每个阶段实施特定的干预措施可以显著改善手术结果和患者安全.
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
480
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
480
Skeletal Muscle Relaxants: Adverse Effects
356
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
356
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
414
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
414
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Classification of Skeletal Muscle Relaxants
2.5K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.5K
Neuromuscular Junction And Blockade
3.0K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
3.0K


